Variables | Without cervix lesions | With cervix lesions | OR (Crude) | OR (Adjusted)b | ||||
---|---|---|---|---|---|---|---|---|
n = 70 (%) | n = 62 (%) | P (Wald’s test) | OR | IC 95% | P (Wald’s test) | OR | IC 95% | |
n (%) | n (%) | |||||||
Demographic and sexual profile | ||||||||
Age | ||||||||
≤ 31 years | 28 (40.0) | 16 (25.8) | 0.161 | 1 | 1 | |||
32–42 years | 19 (27.1) | 25 (40.3) | 0.057 | 2.30 | 0.98–5.42 | 0.316 | 2.27 | 0.46–11.18 |
43 years or more | 23 (32.9) | 21 (33.9) | 0.281 | 1.60 | 0.68–3.75 | 0.470 | 0.57 | 0.12–2.64 |
Residence | ||||||||
Urban area | 60 (85.7) | 41 (66.1) | 1 | |||||
Countryside | 10 (14.3) | 21 (33.9) | 0.010 | 3.07 | 1.31–7.20 | |||
Education level | ||||||||
At least primary school completed | 39 (55.7) | 18 (29.0) | 1 | |||||
Less than primary school | 31 (44.3) | 44 (71.0) | 0.002 | 3.08 | 1.49–6.34 | |||
In a stable relationship | ||||||||
No | 57 (81.4) | 16 (25.8) | 1 | 1 | ||||
Yes | 13 (18.6) | 46 (74.2) | <0.0001 | 12.01 | 5.51–28.87 | < 0.001 | 14.21 | 3.67–55.02 |
N° of sexual partners in all life | ||||||||
1 | 30 (42.9) | 16 (25.8) | 0.121 | 1 | ||||
2–5 | 34 (48.6) | 38 (61.3) | 0.057 | 2.10 | 0.98–4.50 | |||
> 5 | 6 (8.6) | 8 (12.9) | 0.141 | 2.50 | 0.738–8.47 | |||
Ethnic group declared | ||||||||
White | 17 (24.3) | 13 (21.0) | 1 | |||||
No white | 53 (75.7) | 49 (79.0) | 0.650 | 1.21 | 0.53–2.75 | |||
Condom use | ||||||||
Always | 12 (17.6)a | 11 (17.7) | 0.988 | 1 | ||||
Sometimes | 15 (22.1)a | 13 (21.0) | 0.921 | 0.92 | 0.31–2.85 | |||
Never/rarely | 41 (60.3)a | 38 (61.3) | 0.981 | 1.01 | 0.40–2.56 | |||
Contraceptive pills/hormone injection use | ||||||||
No | 44 (62.9) | 43 (69.4) | 1 | |||||
Yes | 26 (37.1) | 19 (30.6) | 0.432 | 0.75 | 0.36–1.55 | |||
Pregnancy | ||||||||
0 | 6 (8.6) | 3 (4.8) | 0.425 | 1 | ||||
1–2 | 34 (48.6) | 26 (41.9) | 0.573 | 1.53 | 0.35–6.70 | |||
≥ 3 | 30 (42.9) | 33 (53.2) | 0.294 | 2.20 | 0.51–9.58 | |||
Abortion | ||||||||
No | 42 (60.0) | 43 (69.4) | 1 | |||||
Yes | 28 (40.0) | 19 (30.6) | 0.264 | 0.66 | 0.32–1.36 | |||
STA detection | ||||||||
HPV | ||||||||
Negative | 52 (74.3) | 9 (14.5) | 1 | < 0.001 | 1 | |||
Positive | 18 (25.7) | 53 (85.5) | <0.001 | 17.01 | 7.01–41.23 | 16.81 | 4.19–67.42 | |
Mollicutes | ||||||||
Negative | 22 (31.4) | 5 (8.1) | 1 | |||||
Positive | 48 (68.6) | 57 (91.9) | 0.002 | 5.23 | 1.84–14.85 | |||
U. parvum (qPCR) | ||||||||
Negative | 29 (41.4) | 13 (21.0) | 1 | 1 | 0.36–5.98 | |||
Positive | 41 (58.6) | 49 (79.0) | 0.013 | 2.66 | 1.23–5.79 | 0.593 | 1.47 | |
U. parvum (PCR) | ||||||||
Negative | 35 (50.0) | 30 (48.4) | 1 | |||||
Positive | 35 (50.0) | 32 (51.6) | 0.853 | 1.07 | 0.54–2.11 | |||
U. parvum serotype 1 | ||||||||
Negative | 61 (87.1) | 61 (98.4) | 1 | |||||
Positive | 9 (12.9) | 1 (1.6) | 0.040 | 0.11 | 0.01–0.90 | |||
U. parvum serotypes 3/14 | ||||||||
Negative | 60 (85.7) | 51 (82.3) | 1 | |||||
Positive | 10 (14.3) | 11 (17.7) | 0.589 | 1.29 | 0.51–3.29 | |||
U. parvum serotype 6 | ||||||||
Negative | 53 (75.7) | 61 (98.4) | 1 | |||||
Positive | 17 (24.3) | 1 (1.6) | 0.004 | 0.05 | 0.007–0.40 | |||
U. urealyticum (qPCR) | ||||||||
Negative | 61 (87.1) | 54 (87.1) | 1 | |||||
Positive | 9 (12.9) | 8 (12.9) | 0.994 | 1.00 | 0.36–2.79 | |||
U. urealyticum (PCR) | ||||||||
Negative | 67 (95.7) | 57 (91.9) | 1 | |||||
Positive | 3 (4.3) | 5 (8.1) | 0.371 | 1.96 | 0.45–8.56 | |||
T. vaginalis | ||||||||
Negative | 66 (94.3) | 24 (38.7) | 1 | 0.003 | 1 | 2.04–35.94 | ||
Positive | 4 (5.7) | 38 (61.3) | <0.001 | 26.13 | 8.43–80.98 | 8.566 | ||
G. vaginalis | ||||||||
Negative | 33 (47.1) | 5 (8.1) | 1 | 0.011 | 1 | 1.53–24.61 | ||
Positive | 37 (52.9) | 57 (91.9) | <0.001 | 10.17 | 3.64–28.41 | 6.13 | ||
C. trachomatis | ||||||||
Negative | 69 (98.6) | 60 (96.8) | 1 | |||||
Positive | 1 (1.4) | 2 (3.2) | 0.501 | 2.30 | 0.20–26.00 | |||
N. gonorrhoeae | ||||||||
Negative | 55 (78.6) | 62 (100.0) | 1 | |||||
Positive | 15 (21.4) | 0 (0) | 0.998 | 0 |